超声引导下针刀松解联合复方倍他米松注射治疗腕管综合征的疗效

Efficacy of ultrasound-guided needle-knife lysis combined with compound betamethasone injection in the treatment of carpal tunnel syndrome

目的 探讨超声引导下针刀松解联合复方倍他米松注射治疗腕管综合征的临床疗效.方法 选择腕管综合征患者40例,分为联合针刀组和倍他米松组,每组20例.联合针刀组采用超声引导下针刀治疗后注射复方倍他米松;倍他米松组仅在超声引导下注射同药,两组患者均治疗两次,每次间隔5d.于治疗后1周、3周及1个月时采用VAS评分评估患者疼痛程度,并按改良MacNab标准评价疗效.结果 与治疗前比较,治疗后各时点两组VAS评分均下降,联合针刀组下降更明显(P＜0.05).治疗后3周时,联合针刀组优良率为100％(20/20例),倍他米松组为90％(18/20例);治疗后1个月时,联合针刀组优良率为95％(19/20例),倍他米松组为80％(16/20例),两组差异有统计学意义(P＜0.05),两组均未见明显并发症.结论 超声引导下针刀松解联合复方倍他米松注射治疗腕管综合征疗效显著,且优于单纯注射复方倍他米松.

Objective To investigate the efficacy of ultrasound-guided needle-knife lysis combined with compound betamethasone injection in the treatment of patients with carpal tunnel syndrome (CTS).Methods Forty patients with CTS were randomly divided into combined needle-knife group and betamethasone group.The patients were treated with ultrasound-guided needle-knife lysis combined with compound betanethasone injection in combined needle-knife group,and compound betamethasone injection alone in betamethasone group,two times per one course,with 5 d intcrval.VAS was used to assess the pain degree at 1,3 weeks and one month after the treatment and modified MacNab to evaluate the efficacy.Results VAS lowered at all time points after the treatment in the two groups,even lower in combined needle-knife group as compared with betamethasone group (P＜0.05).The excellent and good rate was 100％ (20/20 cases) in combined needle-knife lysis group at 3 weeks after the treatment,90％ (18/20 cases) in betamethasone group (P＜0.05),and 95％ (19/20 cases) in combined needle-knife group at one month after the treatment,80％ (16/20 cases) in betamethasone group (P＜0.05).No obvious complications were found.Conclusion The efficacy of ultrasound-guided needle-knife lysis combined with compound betamethasone injection is obvious,and superior to compound betamethasone injection alone in the treatment of carpal tunnel syndrome.